The CLTI Paradigm Shift: Implications for Clinical Trial Design and Endpoints in Endovascular Management of Infrapopliteal Disease.
Saved in:
| Title: | The CLTI Paradigm Shift: Implications for Clinical Trial Design and Endpoints in Endovascular Management of Infrapopliteal Disease. |
|---|---|
| Authors: | Mustapha JA; Lake City Cardiovascular Institute, Lake City, FL, USA., Jacob R; Micro Medical Solutions, Woburn, MA, USA., Miller LE; Miller Scientific, Johnson City, TN, USA., Pena CS; Miami Cardiac and Vascular Institute, Miami, FL, USA., AlMahameed A; Novant Health Heart and Vascular Institute, Charlotte, NC, USA., Dippel EJ; Vascular Institute of the Midwest, Davenport, IA, USA., Beasley RE; Palm Vascular Centers, Miami Beach and Coral Gables, FL, USA., Wiechmann BN; Vascular and Interventional Physicians, Gainesville, FL, USA. |
| Source: | Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists [J Endovasc Ther] 2026 Oct; Vol. 33 (5), pp. 2325-2331. Date of Electronic Publication: 2025 Aug 28. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 100896915 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-1550 (Electronic) Linking ISSN: 15266028 NLM ISO Abbreviation: J Endovasc Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1545-1550 |
|---|---|
| DOI: | 10.1177/15266028251363541 |
